vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Stitch Fix, Inc. (SFIX). Click either name above to swap in a different company.

Stitch Fix, Inc. is the larger business by last-quarter revenue ($342.1M vs $205.4M, roughly 1.7× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -1.9%, a 10.1% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 7.3%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $5.6M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 1.8%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Stitch Fix, Inc. is an online personal styling service in the United States. It uses recommendation algorithms and data science to personalize clothing items based on size, budget and style. The company was founded in 2011 and had an initial public offering in 2017 with a valuation of $1.6 billion. Stitch Fix generated $1.6 billion in net revenue in its fiscal year 2023, a decrease of 21% year-over-year and reported 3,297,000 active clients in September 2023. It is headquartered in San Franci...

COLL vs SFIX — Head-to-Head

Bigger by revenue
SFIX
SFIX
1.7× larger
SFIX
$342.1M
$205.4M
COLL
Growing faster (revenue YoY)
COLL
COLL
+5.6% gap
COLL
12.9%
7.3%
SFIX
Higher net margin
COLL
COLL
10.1% more per $
COLL
8.3%
-1.9%
SFIX
More free cash flow
COLL
COLL
$116.8M more FCF
COLL
$122.4M
$5.6M
SFIX
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
1.8%
SFIX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COLL
COLL
SFIX
SFIX
Revenue
$205.4M
$342.1M
Net Profit
$17.0M
$-6.4M
Gross Margin
62.5%
43.6%
Operating Margin
29.6%
-2.5%
Net Margin
8.3%
-1.9%
Revenue YoY
12.9%
7.3%
Net Profit YoY
35.3%
-1.7%
EPS (diluted)
$0.48
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
SFIX
SFIX
Q4 25
$205.4M
$342.1M
Q3 25
$209.4M
$311.2M
Q2 25
$188.0M
$325.0M
Q1 25
$177.8M
$312.1M
Q4 24
$181.9M
$318.8M
Q3 24
$159.3M
$319.6M
Q2 24
$145.3M
$322.7M
Q1 24
$144.9M
$330.4M
Net Profit
COLL
COLL
SFIX
SFIX
Q4 25
$17.0M
$-6.4M
Q3 25
$31.5M
$-8.6M
Q2 25
$12.0M
$-7.4M
Q1 25
$2.4M
$-6.5M
Q4 24
$12.5M
$-6.3M
Q3 24
$9.3M
$-36.5M
Q2 24
$19.6M
$-21.3M
Q1 24
$27.7M
$-35.5M
Gross Margin
COLL
COLL
SFIX
SFIX
Q4 25
62.5%
43.6%
Q3 25
61.7%
43.6%
Q2 25
57.7%
44.2%
Q1 25
54.8%
44.5%
Q4 24
54.0%
45.4%
Q3 24
60.8%
44.6%
Q2 24
62.5%
45.5%
Q1 24
63.1%
43.4%
Operating Margin
COLL
COLL
SFIX
SFIX
Q4 25
29.6%
-2.5%
Q3 25
29.7%
-3.6%
Q2 25
18.7%
-3.0%
Q1 25
12.2%
-2.9%
Q4 24
20.9%
-2.8%
Q3 24
21.9%
-13.1%
Q2 24
32.7%
-7.7%
Q1 24
34.1%
-11.5%
Net Margin
COLL
COLL
SFIX
SFIX
Q4 25
8.3%
-1.9%
Q3 25
15.0%
-2.8%
Q2 25
6.4%
-2.3%
Q1 25
1.4%
-2.1%
Q4 24
6.9%
-2.0%
Q3 24
5.9%
-11.4%
Q2 24
13.5%
-6.6%
Q1 24
19.1%
-10.8%
EPS (diluted)
COLL
COLL
SFIX
SFIX
Q4 25
$0.48
$-0.05
Q3 25
$0.84
$-0.06
Q2 25
$0.34
$-0.06
Q1 25
$0.07
$-0.05
Q4 24
$0.36
$-0.05
Q3 24
$0.27
$-0.29
Q2 24
$0.52
$-0.18
Q1 24
$0.71
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
SFIX
SFIX
Cash + ST InvestmentsLiquidity on hand
$386.7M
$244.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$204.1M
Total Assets
$1.7B
$530.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
SFIX
SFIX
Q4 25
$386.7M
$244.2M
Q3 25
$285.9M
$234.9M
Q2 25
$222.2M
$234.2M
Q1 25
$197.8M
$219.1M
Q4 24
$162.8M
$253.3M
Q3 24
$120.0M
$247.0M
Q2 24
$271.6M
$244.5M
Q1 24
$318.0M
$229.8M
Stockholders' Equity
COLL
COLL
SFIX
SFIX
Q4 25
$301.7M
$204.1M
Q3 25
$274.8M
$203.0M
Q2 25
$232.2M
$200.4M
Q1 25
$234.4M
$197.8M
Q4 24
$228.8M
$190.5M
Q3 24
$234.3M
$187.0M
Q2 24
$216.6M
$208.9M
Q1 24
$222.2M
$213.3M
Total Assets
COLL
COLL
SFIX
SFIX
Q4 25
$1.7B
$530.7M
Q3 25
$1.6B
$480.6M
Q2 25
$1.6B
$484.7M
Q1 25
$1.6B
$472.6M
Q4 24
$1.7B
$507.1M
Q3 24
$1.6B
$486.9M
Q2 24
$1.1B
$537.0M
Q1 24
$1.1B
$538.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
SFIX
SFIX
Operating Cash FlowLast quarter
$123.0M
$10.9M
Free Cash FlowOCF − Capex
$122.4M
$5.6M
FCF MarginFCF / Revenue
59.6%
1.6%
Capex IntensityCapex / Revenue
0.3%
1.6%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$4.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
SFIX
SFIX
Q4 25
$123.0M
$10.9M
Q3 25
$78.4M
$7.0M
Q2 25
$72.4M
$20.5M
Q1 25
$55.4M
$-16.2M
Q4 24
$84.6M
$14.3M
Q3 24
$-9.0M
$8.2M
Q2 24
$67.4M
$21.7M
Q1 24
$61.9M
$-22.3M
Free Cash Flow
COLL
COLL
SFIX
SFIX
Q4 25
$122.4M
$5.6M
Q3 25
$78.3M
$2.8M
Q2 25
$72.4M
$16.0M
Q1 25
$54.6M
$-19.4M
Q4 24
$84.1M
$9.9M
Q3 24
$-9.2M
$4.5M
Q2 24
$67.1M
$18.9M
Q1 24
$61.4M
$-26.1M
FCF Margin
COLL
COLL
SFIX
SFIX
Q4 25
59.6%
1.6%
Q3 25
37.4%
0.9%
Q2 25
38.5%
4.9%
Q1 25
30.7%
-6.2%
Q4 24
46.2%
3.1%
Q3 24
-5.8%
1.4%
Q2 24
46.2%
5.9%
Q1 24
42.3%
-7.9%
Capex Intensity
COLL
COLL
SFIX
SFIX
Q4 25
0.3%
1.6%
Q3 25
0.1%
1.4%
Q2 25
0.0%
1.4%
Q1 25
0.4%
1.0%
Q4 24
0.3%
1.4%
Q3 24
0.2%
1.2%
Q2 24
0.2%
0.9%
Q1 24
0.4%
1.1%
Cash Conversion
COLL
COLL
SFIX
SFIX
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
Q2 24
3.44×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons